Use of IV iodinated and gadolinium contrast media in the pregnant or lactating patient: Self-assessment module

American Journal of Roentgenology

Volumn 193, Issue 6 SUPPL., 2009, Pages

  Lee, Susanna I ^a   Chew, Felix S ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b University of Seattle   (United States)

Author keywords

Amniotic fluid; Breast feeding; Fetus; Placenta; Thyroid function

Indexed keywords

GADOLINIUM; IODINATED CONTRAST MEDIUM; CONTRAST MEDIUM; IODINE DERIVATIVE;

ADULT; AMNION FLUID; BREAST FEEDING; CLINICAL PRACTICE; CONTINUING EDUCATION; CONTRAST ENHANCEMENT; FEMALE; FETUS; GOITER; HUMAN; MEDICAL DOCUMENTATION; NOTE; PATIENT COUNSELING; PLACENTA; PRACTICE GUIDELINE; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; THYROID DISEASE; THYROID FUNCTION TEST; TISSUE DISTRIBUTION; URINARY EXCRETION; BREAST MILK; DOSE RESPONSE; FETOMATERNAL TRANSFUSION; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LACTATION; METABOLISM; REVIEW;

CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GADOLINIUM; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; IODINE COMPOUNDS; LACTATION; MATERNAL-FETAL EXCHANGE; MILK, HUMAN; PREGNANCY;

EID: 74049160753     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.07.7135     Document Type: Note

References (16)

1. Bloomfield TH, Hawkins DF. The effects of drugs on the human fetus. In: Philipp E, Setchell M, eds. Scientific foundations of obstetrics and gynaecology, 4th ed. Oxford, UK: Butterworth-Heinemann, 1991:320
2. van der Molen AJ, Thomsen HS, Morcos SK, and members of Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Effect of iodinated contrast media on thyroid function in adults. Eur Radiol 2004; 14:902-907
3. Cacheris WP, Quay SC, Rocklage SM. The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn Reson Imaging 1990; 8:467-481
4. Robuschi G, Montermini M, Alboni A, et al. Cord blood iodothyronine and thyrotropin concentrations in newborns of mothers exposed to povidone iodine in the last trimester. J Endocrinol Invest 1987; 10:183-186
5. Vagenakis AG, Braverman LE. Adverse effects of iodides on thyroid function. Med Clin North Am 1975; 59:1075-1088
6. Atwell TD, Lteif AN, Brown DL, McCann M, Townsend JE, Leroy AJ. Neonatal thyroid function after administration of IV iodinated contrast agent to 21 pregnant patients. AJR 2008; 191:268-271
7. Etling N, Gehin-Fouque F, Vielh JP, Gautray JP. The iodine content of amniotic fluid and placental transfer of iodinated drugs. Obstet Gynecol 1979; 53:376-380
8. American College of Radiology Committee on Drugs and Contrast Media. Manual on contrast media, 6th ed. Reston, VA: American College of Radiology, 2004:61-66
9. Webb JA, Thomsen HS, Morcos SK; members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 2005; 15:1234-1240
10. Shellock FG, Kanal E. Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging 1999; 10:477-484
11. Marcos HB, Semelka RC, Worowattanakul S. Normal placenta: gadolinium-enhanced dynamic MR imaging. Radiology 1997; 205:493-496
12. Shellock FG, Kanal E. Bioeffects and safety of MR procedures. In: Edelman RR, Hesselink JR, Zlatkin MB, eds. Clinical magnetic resonance imaging, 2nd ed. Philadelphia, PA: Saunders, 1996:429
13. Johansen JG. Assessment of a non-ionic contrast medium (Amipaque) in the gastrointestinal tract. Invest Radiol 1978; 13:523-527
14. Nielsen ST, Matheson I, Rasmussen JN, Skinnemoen K, Andrew E, Hafsahl G. Excretion of iohexol and metrizoate in human breast milk. Acta Radiol 1987; 28:523-526
15. Schmiedl U, Maravilla KR, Gerlach R, Dowling CA. Excretion of gadopentetate dimeglumine in human breast milk. AJR 1990; 154:1305-1306
16. Rofsky NM, Weinreb JC, Litt AW. Quantitative analysis of gadopentetate dimeglumine excreted in breast milk. J Magn Reson Imaging 1993; 3:131-132